Lista de obras -

"Very late" relapses in Hodgkin's disease patients: a rare but real phenomenon

artículo científico publicado en 1992

3'-Azido 3'-deoxythymidine + methotrexate as a novel antineoplastic combination in the treatment of human immunodeficiency virus-related non-Hodgkin's lymphomas

artículo científico publicado en 1997

A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi

artículo científico publicado en 2018

Adrenomedullin in the growth modulation and differentiation of acute myeloid leukemia cells

artículo científico publicado en 2016

Aleukemic granulocytic sarcoma with associated T-cell lymphoblastic lymphoma in the same lymph node: morphologic features and molecular signatures

artículo científico publicado en 2008

Alpha recombinant interferon in the treatment of mycosis fungoides (MF)

scientific article published on 01 July 1987

Alpha-2b recombinant interferon (Intron) in Hodgkin's lymphoma: therapeutic perspective

artículo científico publicado en 1990

Analysis of Toxicity and Efficacy of Subcutaneous Cladribine at Reduced or Standard Doses (Five Versus Seven Consecutive Days) In Patients with Hairy Cell Leukemia (HCL) In the ICGHCL2004 Protocol by the Italian Cooperative Group on Hcl ⬇️

scholarly article

Anaplastic large cell lymphoma (CD30 +/Ki-1+): results of a prospective clinico-pathological study of 69 cases.

artículo científico publicado en 1994

Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy ⬇️

artículo científico publicado el 1 de agosto de 1998

Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratories

artículo científico publicado en 2017

Autologous stem cell transplantation for acute myeloid leukemia patients in first complete remission: a 10-year follow-up study of 118 patients

artículo científico publicado en 2005

Avidin-biotin immunoadsorption for ex vivo bone marrow purging: effect of percentage of target cells and flow rate

artículo científico publicado en 1988

Babesia infection in Italy

artículo científico publicado en 2004

BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients

artículo científico publicado en 2011

Bendamustine, etoposide, cytarabine, melphalan, and autologous stem cell rescue produce a 72% 3-year PFS in resistant lymphoma

artículo científico publicado en 2014

Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse

scientific article published on 02 January 2020

CEOP regimen in the treatment of advanced low-grade non-Hodgkin's lymphomas: preliminary report.

artículo científico publicado en 1990

Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study

artículo científico publicado en 2020

Clinical and experimental efficacy of gemtuzumab ozogamicin in core binding factor acute myeloid leukemia.

artículo científico publicado en 2017

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

artículo científico publicado en 2020

Complete remission induced by thalidomide in a case of angioimmunoblastic T-cell lymphoma refractory to autologous stem cell transplantation

artículo científico publicado en 2008

Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-up.

artículo científico publicado en 2015

Concomitant chronic lymphocytic leukemia and acute myeloid leukemia: Evidence of simultaneous expansion of two independent clones

scientific article published on 01 May 2006

Critical value of laparotomy with splenectomy in Stage III Hodgkin's disease as restaging procedure after chemotherapy ⬇️

artículo científico publicado el 1 de julio de 1988

Cytogenetic evidence of metastatic myxoid liposarcoma and therapy-related myelodysplastic syndrome in a bone marrow biopsy

artículo científico publicado en 2009

EUTOS score predicts long-term outcome but not optimal response to imatinib in patients with chronic myeloid leukaemia

artículo científico publicado en 2013

Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial

artículo científico publicado en 2003

Effects of a new bifunctional alkylating agent (PTT-119) on in vitro growth of human cell lines and normal myeloid progenitors (CFU-GM)

scientific article published on 01 May 1988

Efficacy and toxicity of Decitabine in patients with acute myeloid leukemia (AML): A multicenter real-world experience

artículo científico publicado en 2018

Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients.

artículo científico publicado en 1999

Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients.

artículo científico publicado en 2018

Familial hemophagocytic lymphohistiocytosis may present during adulthood: clinical and genetic features of a small series.

artículo científico publicado en 2012

Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia ⬇️

artículo científico publicado el 1 de julio de 1991

Flai (fludarabine, cytarabine, idarubicin) plus low-dose gemtuzumab ozogamicin as induction therapy in cd33-positive aml: Final results and long term outcome of a phase ii multicenter clinical trial

artículo científico publicado en 2018

Fludarabine-based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients

artículo científico publicado en 1999

Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party

article by Gabriele Gugliotta et al published 26 May 2011 in Blood

Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior

artículo científico publicado en 2009

High-dose therapy followed by autologous bone marrow transplantation (ABMT) in previously untreated non-Hodgkin's lymphoma

artículo científico publicado en 1986

High-dose therapy with autologous transplantation for Hodgkin's disease: the Bologna experience

scientific article published on 01 May 2003

High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience

artículo científico publicado en 2004

Hodgkin's disease: summary of twenty years' experience ⬇️

artículo científico publicado el 1 de noviembre de 1992

How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?

artículo científico publicado en 1999

Imatinib and hyperlipidemia

artículo científico publicado en 2005

Intensive chemotherapy regimen in high-grade non Hodgkin's lymphomas

artículo científico publicado en 1987

Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia

scientific article published on 16 November 2011

Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin's lymphoma

artículo científico publicado en 2017

Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma

artículo científico publicado en 2017

MACOP-B vs F-MACHOP in the treatment of high-grade non-Hodgkin's lymphomas

artículo científico publicado el 1 de enero de 1991

MN (N = Novantrone) COP-B therapy on high and intermediate grade non-Hodgkin's lymphoma: an alternative to MA (A = adriamycin) COP-B?

artículo científico publicado en 1991

Massive mediastinal involvement in stage I-II Hodgkin's disease: response to combined modality treatment

artículo científico publicado en 1992

Meningitis and septicaemia in adults splenectomized for Hodgkin's disease

artículo científico publicado en 1986

Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe

artículo científico publicado en 2003

Mopp chemotherapy in the treatment of stage IV Hodgkin's disease

artículo científico publicado en 1985

Multicentre survey to explore current survival of patients with acute myeloid leukaemia who failed induction chemotherapy.

artículo científico publicado en 2015

Mycosis fungoides: a therapeutical review ⬇️

artículo científico publicado el 1 de marzo de 1991

Non Hodgkin's lymphomas: prognostic feature of 55 patients treated with MEVAP chemotherapy

artículo científico publicado en 1984

Non-Hodgkin's lymphomas in leukaemic phase: incidence, prognosis and therapeutic implications.

artículo científico publicado en 1985

Observational retrospective study of vascular modulator changes during treatment in essential thrombocythemia.

artículo científico publicado en 2017

Pattern of Use and Long-Term Safety of Tyrosine Kinase Inhibitors: A Decade of Real-World Management of Chronic Myeloid Leukemia

artículo científico publicado en 2018

Phase II cooperative study with a new alkylating drug, PTT-119, in the treatment of non-Hodgkin's lymphomas

artículo científico publicado en 1990

Phase II study of a new alkylating agent (PTT-119) in resistant-relapsed non-Hodgkin's lymphomas

artículo científico publicado en 1989

Phase II study with a new alkylating agent (PTT-119) in lymphoid malignancies

scientific article published on 01 November 1988

Phase III comparative trial (m-BACOD v m-BNCOD) in the treatment of stage II to IV non-Hodgkin's lymphomas with intermediate- or high-grade histology

artículo científico publicado en 1990

Primary cardiac onset of disseminated Burkitt's lymphoma

artículo científico publicado en 2007

Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy

artículo científico publicado en 2001

Prognostic significance of circulating and endothelial progenitor cell markers in type 2 diabetic foot.

artículo científico publicado en 2014

Prognostic value of Positron Emission Tomography/Computed Tomography in patients with Lymphoma treated with autologous stem cell transplantation (ASCT) for relapsed/refractory or high risk disease.

artículo científico publicado en 2015

Prompt Hematological Recovery in Response to a Combination of Pegylated Interferon α-2a and Rituximab in a Profoundly Immuno-Suppressed Hairy Cell Leukemia Patient with a Mycobacterial Infection at Onset: Benefits and Drawbacks of Rapid Immune Recon

artículo científico publicado en 2022

Prostatic lymphoma

artículo científico publicado en 1983

Psychological screening of onco-hematologic inpatients: Distress Thermometer administration

artículo científico publicado en 2015

RASGRP1/APTX Ratio Is a Strong Biomarker of Clinical Response and Survival In AML Patients Treated with Tipifarnib: A Phase I-II Preliminary Results ⬇️

scholarly article

Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin's lymphoma patients.

artículo científico publicado en 2002

Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma

article by P L Zinzani et al published February 2000 in Journal of Clinical Oncology

Rational basis for the use of alfa-2a recombinant interferon in the treatment of mycosis fungoides (MF)

artículo científico publicado en 1990

Re-evaluation of prognosis in stages I and II Hodgkin's disease with bulky mediastinal involvement

artículo científico publicado en 1987

Role of blood cells dynamism on hemostatic complications in low-risk patients with essential thrombocythemia

artículo científico publicado en 2015

Septicaemia after Splenectomy for Hodgkin’s Disease: Two Episodes in the Same Patient, 9 and 13 Years after Cure

artículo científico publicado en 1988

Spinal cord compression in Hodgkin's disease

artículo científico publicado en 1984

Stage I high-grade non-Hodgkin's lymphomas: a retrospective analysis.

artículo científico publicado en 1991

The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib

artículo científico publicado en 2017

Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients

artículo científico publicado en 1998

Two novel missense mutations in EPOR gene causes erythrocytosis in two unrelated patients

artículo científico publicado en 2016

VNCOP-B regimen in the treatment of high-grade non-Hodgkin's lymphoma in the elderly

scientific article published on 01 November 1993

Value of gemcitabine treatment in heavily pretreated Hodgkin's disease patients.

artículo científico publicado en 2000

What does preemptive antifungal treatment really mean?

artículo científico publicado en 2010

Lista de obras de

"Very late" relapses in Hodgkin's disease patients: a rare but real phenomenon

3'-Azido 3'-deoxythymidine + methotrexate as a novel antineoplastic combination in the treatment of human immunodeficiency virus-related non-Hodgkin's lymphomas

A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi

Adrenomedullin in the growth modulation and differentiation of acute myeloid leukemia cells

Aleukemic granulocytic sarcoma with associated T-cell lymphoblastic lymphoma in the same lymph node: morphologic features and molecular signatures

Alpha recombinant interferon in the treatment of mycosis fungoides (MF)

Alpha-2b recombinant interferon (Intron) in Hodgkin's lymphoma: therapeutic perspective

Analysis of Toxicity and Efficacy of Subcutaneous Cladribine at Reduced or Standard Doses (Five Versus Seven Consecutive Days) In Patients with Hairy Cell Leukemia (HCL) In the ICGHCL2004 Protocol by the Italian Cooperative Group on Hcl ⬇️

Anaplastic large cell lymphoma (CD30 +/Ki-1+): results of a prospective clinico-pathological study of 69 cases.

Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy ⬇️

Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratories

Autologous stem cell transplantation for acute myeloid leukemia patients in first complete remission: a 10-year follow-up study of 118 patients

Avidin-biotin immunoadsorption for ex vivo bone marrow purging: effect of percentage of target cells and flow rate

Babesia infection in Italy

BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients

Bendamustine, etoposide, cytarabine, melphalan, and autologous stem cell rescue produce a 72% 3-year PFS in resistant lymphoma

Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse

CEOP regimen in the treatment of advanced low-grade non-Hodgkin's lymphomas: preliminary report.

Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study

Clinical and experimental efficacy of gemtuzumab ozogamicin in core binding factor acute myeloid leukemia.

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Complete remission induced by thalidomide in a case of angioimmunoblastic T-cell lymphoma refractory to autologous stem cell transplantation

Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-up.

Concomitant chronic lymphocytic leukemia and acute myeloid leukemia: Evidence of simultaneous expansion of two independent clones

Critical value of laparotomy with splenectomy in Stage III Hodgkin's disease as restaging procedure after chemotherapy ⬇️

Cytogenetic evidence of metastatic myxoid liposarcoma and therapy-related myelodysplastic syndrome in a bone marrow biopsy

EUTOS score predicts long-term outcome but not optimal response to imatinib in patients with chronic myeloid leukaemia

Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial

Effects of a new bifunctional alkylating agent (PTT-119) on in vitro growth of human cell lines and normal myeloid progenitors (CFU-GM)

Efficacy and toxicity of Decitabine in patients with acute myeloid leukemia (AML): A multicenter real-world experience

Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients.

Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients.

Familial hemophagocytic lymphohistiocytosis may present during adulthood: clinical and genetic features of a small series.

Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia ⬇️

Flai (fludarabine, cytarabine, idarubicin) plus low-dose gemtuzumab ozogamicin as induction therapy in cd33-positive aml: Final results and long term outcome of a phase ii multicenter clinical trial

Fludarabine-based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients

Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party

Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior

High-dose therapy followed by autologous bone marrow transplantation (ABMT) in previously untreated non-Hodgkin's lymphoma

High-dose therapy with autologous transplantation for Hodgkin's disease: the Bologna experience

High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience

Hodgkin's disease: summary of twenty years' experience ⬇️

How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?

Imatinib and hyperlipidemia

Intensive chemotherapy regimen in high-grade non Hodgkin's lymphomas

Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia

Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin's lymphoma

Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma

MACOP-B vs F-MACHOP in the treatment of high-grade non-Hodgkin's lymphomas

MN (N = Novantrone) COP-B therapy on high and intermediate grade non-Hodgkin's lymphoma: an alternative to MA (A = adriamycin) COP-B?

Massive mediastinal involvement in stage I-II Hodgkin's disease: response to combined modality treatment

Meningitis and septicaemia in adults splenectomized for Hodgkin's disease

Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe

Mopp chemotherapy in the treatment of stage IV Hodgkin's disease

Multicentre survey to explore current survival of patients with acute myeloid leukaemia who failed induction chemotherapy.

Mycosis fungoides: a therapeutical review ⬇️

Non Hodgkin's lymphomas: prognostic feature of 55 patients treated with MEVAP chemotherapy

Non-Hodgkin's lymphomas in leukaemic phase: incidence, prognosis and therapeutic implications.

Observational retrospective study of vascular modulator changes during treatment in essential thrombocythemia.

Pattern of Use and Long-Term Safety of Tyrosine Kinase Inhibitors: A Decade of Real-World Management of Chronic Myeloid Leukemia

Phase II cooperative study with a new alkylating drug, PTT-119, in the treatment of non-Hodgkin's lymphomas

Phase II study of a new alkylating agent (PTT-119) in resistant-relapsed non-Hodgkin's lymphomas

Phase II study with a new alkylating agent (PTT-119) in lymphoid malignancies

Phase III comparative trial (m-BACOD v m-BNCOD) in the treatment of stage II to IV non-Hodgkin's lymphomas with intermediate- or high-grade histology

Primary cardiac onset of disseminated Burkitt's lymphoma

Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy

Prognostic significance of circulating and endothelial progenitor cell markers in type 2 diabetic foot.

Prognostic value of Positron Emission Tomography/Computed Tomography in patients with Lymphoma treated with autologous stem cell transplantation (ASCT) for relapsed/refractory or high risk disease.

Prompt Hematological Recovery in Response to a Combination of Pegylated Interferon α-2a and Rituximab in a Profoundly Immuno-Suppressed Hairy Cell Leukemia Patient with a Mycobacterial Infection at Onset: Benefits and Drawbacks of Rapid Immune Recon

Prostatic lymphoma

Psychological screening of onco-hematologic inpatients: Distress Thermometer administration

RASGRP1/APTX Ratio Is a Strong Biomarker of Clinical Response and Survival In AML Patients Treated with Tipifarnib: A Phase I-II Preliminary Results ⬇️

Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin's lymphoma patients.

Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma

Rational basis for the use of alfa-2a recombinant interferon in the treatment of mycosis fungoides (MF)

Re-evaluation of prognosis in stages I and II Hodgkin's disease with bulky mediastinal involvement

Role of blood cells dynamism on hemostatic complications in low-risk patients with essential thrombocythemia

Septicaemia after Splenectomy for Hodgkin’s Disease: Two Episodes in the Same Patient, 9 and 13 Years after Cure

Spinal cord compression in Hodgkin's disease